Short-Term Outcomes After Myopericarditis Related to COVID-19 Vaccination.

Competing Interests: Funding Support and Author Disclosures Dr Pareek is on advisory boards for AstraZeneca and Janssen-Cilag; and has received speaker honoraria from AstraZeneca, Bayer, Boehringer Ingelheim, and Janssen-Cilag. Dr Khera has received support from the National Heart, Lung, and Blood Institute of the National Institutes of Health (grant K23HL153775) outside of the submitted work. Dr Miller is a consultant for Eidos, Pfizer, Siemens, Alnylam, and Roivant; and has received grant support from Eidos, Pfizer, and Argospect. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.